ArticleJournal of asthma and allergy2022

Anti-IL-5 Agents for the Treatment of Idiopathic Chronic Eosinophilic Pneumonia: A Case Series.

Hiroki Tashiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.